14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.74 $3.18 Tuesday, 23rd Apr 2024 GLYC stock ended at $1.84. This is 1.94% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 6.90% from a day low at $1.74 to a day high of $1.86.
90 days $1.74 $3.52
52 weeks $1.11 $3.53

Historical GlycoMimetics prices

Date Open High Low Close Volume
Feb 09, 2024 $3.20 $3.33 $3.20 $3.29 216 840
Feb 08, 2024 $3.15 $3.34 $3.12 $3.20 359 610
Feb 07, 2024 $3.18 $3.25 $3.09 $3.18 256 842
Feb 06, 2024 $3.11 $3.28 $3.11 $3.20 264 717
Feb 05, 2024 $2.91 $3.15 $2.81 $3.13 270 809
Feb 02, 2024 $2.90 $3.04 $2.72 $2.95 319 298
Feb 01, 2024 $3.03 $3.03 $2.72 $2.93 598 252
Jan 31, 2024 $3.37 $3.47 $2.92 $3.00 632 829
Jan 30, 2024 $3.18 $3.40 $3.06 $3.40 241 598
Jan 29, 2024 $3.16 $3.50 $3.16 $3.20 612 751
Jan 26, 2024 $3.14 $3.24 $3.10 $3.18 203 172
Jan 25, 2024 $3.07 $3.23 $2.94 $3.16 221 753
Jan 24, 2024 $3.50 $3.52 $2.90 $3.07 490 541
Jan 23, 2024 $3.12 $3.53 $3.07 $3.49 644 470
Jan 22, 2024 $2.90 $3.18 $2.90 $3.12 354 192
Jan 19, 2024 $3.03 $3.09 $2.92 $2.98 270 002
Jan 18, 2024 $2.84 $3.12 $2.66 $3.06 364 098
Jan 17, 2024 $2.82 $2.93 $2.45 $2.87 759 973
Jan 16, 2024 $3.12 $3.16 $2.87 $2.91 336 967
Jan 12, 2024 $3.00 $3.18 $2.99 $3.11 278 811
Jan 11, 2024 $2.99 $3.14 $2.72 $3.03 488 691
Jan 10, 2024 $3.01 $3.13 $2.92 $2.97 277 389
Jan 09, 2024 $2.93 $3.07 $2.83 $3.02 272 354
Jan 08, 2024 $2.78 $2.91 $2.78 $2.90 142 906
Jan 05, 2024 $2.96 $2.96 $2.67 $2.80 381 775
Click to get the best stock tips daily for free!

About GlycoMimetics

GlycoMimetics GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing G... GLYC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT